CURRENT ISSUES IN MOLECULAR BIOLOGY
Scope & Guideline
Advancing Knowledge in Molecular Biology
Introduction
Aims and Scopes
- Molecular Mechanisms of Disease:
This area encompasses research on the molecular pathways involved in various diseases, including cancer, neurodegenerative conditions, and autoimmune disorders. Studies often explore the genetic, epigenetic, and proteomic factors that influence disease progression and response to treatment. - Therapeutic Applications of Biomolecular Research:
The journal publishes studies that investigate the therapeutic potential of biomolecules, including natural compounds, peptides, and small molecules. This includes research on drug development, gene therapy, and the application of molecular techniques in clinical settings. - Genetic and Genomic Studies:
Research in this scope focuses on the identification and characterization of genetic variants associated with diseases, the use of next-generation sequencing technologies, and the exploration of gene expression profiles in various biological contexts. - Cellular and Molecular Biology Techniques:
The journal showcases innovative methodologies and technologies used in molecular biology, including CRISPR/Cas9 gene editing, transcriptomics, proteomics, and bioinformatics approaches that facilitate the understanding of complex biological systems. - Plant and Microbial Molecular Biology:
This area includes studies on plant genetics, responses to environmental stresses, and the molecular interactions between plants and microorganisms, highlighting the importance of these interactions in agriculture and biotechnology.
Trending and Emerging
- Personalized Medicine and Genomics:
Research aimed at understanding individual genetic profiles and their implications for personalized treatment strategies is on the rise. This includes studies leveraging genomic data to tailor therapies for cancer and other diseases. - Microbiome Research and Its Implications:
The exploration of the human microbiome and its impact on health, disease, and treatment outcomes is emerging as a significant area of interest. This includes studies on the gut-brain axis, microbiome interactions with drugs, and their role in metabolic disorders. - Molecular Mechanisms of Aging:
There is an increasing focus on the molecular pathways involved in aging and age-related diseases. Research is exploring how cellular senescence, oxidative stress, and metabolic dysregulation contribute to aging and related pathologies. - CRISPR and Gene Editing Technologies:
The application of CRISPR and other gene editing technologies is rapidly growing, with studies focusing on their therapeutic potential, ethical implications, and innovative applications in various fields, including agriculture and medicine. - Immunotherapy and Cancer Biology:
Research in cancer immunotherapy is expanding, with a focus on understanding the immune landscape of tumors and developing novel therapeutic strategies that harness the body's immune response against cancer.
Declining or Waning
- Traditional Pharmacology:
Research focused solely on traditional pharmacological approaches without integration of molecular mechanisms or personalized medicine strategies is becoming less prevalent. The trend is shifting towards more complex interactions and novel drug discovery methods. - Single-Disease Focus Studies:
Studies that concentrate exclusively on single diseases without considering comorbidities or broader biological contexts are less common. There is a growing trend towards integrative approaches that consider multiple factors affecting health and disease. - Basic Laboratory Techniques without Novel Insights:
Papers that primarily report basic laboratory techniques or standard protocols without new applications or insights are seeing a reduction in publication. The emphasis is now on innovative methodologies that provide significant contributions to the field. - In Vivo Studies with Limited Clinical Relevance:
Research involving in vivo studies that do not directly translate to clinical applications or lack a clear connection to human health issues are becoming less favored. The journal is increasingly prioritizing studies that bridge laboratory findings with clinical implications. - General Reviews without Novel Perspectives:
There is a noticeable decline in the publication of general review articles that do not offer new perspectives or critical analyses. The focus is shifting towards comprehensive reviews that synthesize recent findings and propose future research directions.
Similar Journals
JOURNAL OF NEUROGENETICS
Pioneering Insights into Neurogenetics and Brain DisordersJOURNAL OF NEUROGENETICS, published by Taylor & Francis Ltd in the United Kingdom, is an influential platform for research and discussion in the dynamic field of neurogenetics. With an ISSN of 0167-7063 and an E-ISSN of 1563-5260, this journal has been committed to advancing our understanding of the genetic underpinnings of neurological conditions since its inception in 1983. Presently categorized in the Q3 quartile for Cellular and Molecular Neuroscience and Q2 for Genetics as of 2023, it serves as an essential resource for researchers and professionals seeking insights into the genetic factors influencing nervous system function and disorder. Although it does not offer open access, the journal remains a critical repository of knowledge with a broad scope that invites contributions spanning molecular genetics to neurobiology. With its rankings in Scopus reflecting a keen focus on robust academic standards, the JOURNAL OF NEUROGENETICS is vital for those dedicated to pioneering research and finding solutions in neurogenetics, making it a significant asset to students, scholars, and industry experts alike.
JOURNAL OF BIOSCIENCES
Elevating Knowledge in Molecular Biology and GeneticsJOURNAL OF BIOSCIENCES, published by the Indian Academy of Sciences, has established itself as a pioneering platform in the fields of biosciences, encompassing diverse research areas such as agricultural and biological sciences, biochemistry, genetics, molecular biology, and medicine. With an impressive trajectory since its inception in 1979, the journal has achieved notable recognition, securing a Q1 ranking in Agricultural and Biological Sciences and maintaining its place in the top quartiles for Biochemistry and Medicine as of 2023. With Scopus rankings placing it at #32 in General Agricultural and Biological Sciences and #65 in General Biochemistry, Genetics, and Molecular Biology, the journal reaches the 85th and 70th percentiles respectively, reflecting its impact and relevance in current scientific discourse. Although it does not offer open access, the JOURNAL OF BIOSCIENCES remains crucial for researchers, professionals, and students dedicated to advancing knowledge and innovation within the biosciences, providing a vibrant forum for high-quality research and comprehensive reviews.
Molecular Genetics Microbiology and Virology
Innovating Insights in Virology and Molecular GeneticsMolecular Genetics Microbiology and Virology is an esteemed academic journal published by PLEIADES PUBLISHING INC, specializing in the complex interplay of genetics, microbiology, and virology. Established in 2007, this journal serves as a crucial platform for researchers and professionals committed to advancing our understanding of infectious diseases and molecular biology. Despite its current categorization in Q4 across several fields, the journal aims to evolve and foster significant discourse within the scientific community. While not an open access journal, it provides essential insights and high-quality research articles that contribute to the body of knowledge in molecular genetics and related disciplines. Located in the vibrant research landscape of New York, USA, the journal also encourages new submissions that address cutting-edge research topics and emerging trends in infectious diseases, thereby appealing to both emerging scholars and seasoned experts alike.
Molecular Syndromology
Exploring the Intersection of Genetics and SyndromesMolecular Syndromology is a premier journal focused on the intricate connections between molecular genetics and syndromology, fostering discussions that advance our understanding of genetic disorders and their clinical implications. Published by KARGER, a distinguished name in medical and scientific publishing, this journal serves as a valuable platform for researchers, clinicians, and students in the field of genetics. With its ISSN 1661-8769 and E-ISSN 1661-8777, the journal has gained recognition in its category, currently positioned in the Q4 quartile for both genetic and clinical genetics disciplines according to the latest metrics. Despite being indexed lower in Scopus rankings, it addresses crucial gaps in research and offers open access options that enhance visibility and dissemination of knowledge. As it continues to converge from 2010 to 2024, Molecular Syndromology aims to bridge the gap between molecular research and its clinical applications, making a significant impact in the evolving landscape of genetic medicine.
Vavilovskii Zhurnal Genetiki i Selektsii
Advancing the Frontiers of Genetics and SelectionVavilovskii Zhurnal Genetiki i Selektsii, with ISSN 2500-0462 and E-ISSN 2500-3259, is a distinguished open-access journal published by the Russian Academy of Sciences, Institute of Cytology and Genetics. Since transitioning to open access in 2013, the journal has been dedicated to advancing research and discourse in the fields of genetics and selection, particularly within agricultural and biological sciences. With a current ranking of Q2 in Agricultural and Biological Sciences and Q3 in Biochemistry, Genetics and Molecular Biology according to Scopus, it serves as a pivotal platform for researchers, professionals, and students to disseminate their findings and collaborate on innovative ideas. The journal, housed in the vibrant academic environment of Novosibirsk, Russia, publishes a diverse range of articles that contribute to the ongoing evolution of genetic studies and practical applications in agriculture. Its commitment to quality and accessibility ensures it plays an essential role in the global scientific community, fostering knowledge that bridges theoretical research and practical implementation.
Genes
Innovating understanding in clinical genetics and molecular biology.Genes is a leading open-access journal published by MDPI that focuses on advancing the field of genetics and genomics. Established in 2010 and based in Basel, Switzerland, this journal has made significant strides in promoting innovative research in both clinical genetics and molecular biology. With an impact factor reflecting its relevance and quality, Genes has been classified in the Q2 quartile for Genetics and the Q3 quartile for clinical Genetics as of 2023. The journal provides an accessible platform for researchers, professionals, and students to disseminate their findings and explore emerging trends across the genetics landscape. Accessible online since its inception, Genes allows for continuous engagement and collaboration within the scientific community, fostering a deeper understanding of genetic mechanisms and their implications in health and disease.
MOLECULAR BIOLOGY REPORTS
Illuminating the pathways of molecular mechanisms.MOLECULAR BIOLOGY REPORTS, published by SPRINGER, is a distinguished journal that serves the vibrant fields of genetics, medicine, and molecular biology. With a rich publication history dating back to 1973, this journal has evolved into a hub for innovative and impactful research, garnering a respectable 2023 Impact Factor indicative of its influence within the academic community. Operating from the Netherlands, it focuses on disseminating high-quality research findings that advance our understanding of molecular mechanisms underlying biological processes. Though not open access, the journal offers various subscription options to ensure accessibility to its comprehensive content. Currently classified in the Q2 quartile in Medicine (miscellaneous) and Q3 in both Genetics and Molecular Biology, MOLECULAR BIOLOGY REPORTS is committed to fostering scholarly dialogue and collaboration among researchers, professionals, and students dedicated to exploring the complexities of life at the molecular level.
FEBS Open Bio
Exploring the depths of biochemistry, genetics, and beyond.FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.
GENETICS AND MOLECULAR RESEARCH
Illuminating the Pathways of Genetic DiscoveryGENETICS AND MOLECULAR RESEARCH is a distinguished academic journal published by FUNPEC-EDITORA, focusing on the rapidly evolving fields of genetics and molecular biology. Since its inception in 2002, the journal has provided a platform for high-quality research and advancements that contribute to our understanding of genetic mechanisms and molecular interactions. With an impressive convergence period extending through 2024, this open-access journal presents vital insights while maintaining accessibility for researchers, professionals, and students alike. Though currently positioned in the Q4 quartile in Genetics, Medicine (Miscellaneous), and Molecular Biology as per the latest 2023 rankings, its persistent publication efforts aim to elevate its influence within the academic community. Researchers are invited to explore groundbreaking studies that may inform future developments in these critical scientific domains.
NATURE REVIEWS GENETICS
Unveiling the Complexities of Genetic Science.NATURE REVIEWS GENETICS, published by NATURE PORTFOLIO, stands as a leading journal in the field of genetics, boasting a remarkable reputation reflected in its Q1 ranking across multiple categories including Genetics, Clinical Genetics, and Molecular Biology. With an impressive percentile of 99th in both Genetics and Clinical Genetics, as well as a solid rank in Molecular Biology, this journal is pivotal for researchers, professionals, and students alike who seek to stay informed on the latest advancements and comprehensive reviews in genetic research. The journal's scope encompasses a wide array of topics, providing in-depth insights from fundamental genetic principles to clinical applications, underscoring its importance in bridging basic science and medical practice. Though not an open-access publication, it remains accessible through various academic institutions, enhancing its reach and influence within the scientific community. With publication years spanning from 2000 to 2024, NATURE REVIEWS GENETICS continues to shape the future of genetics research and education.